Accelerant vs Ethos Technologies
ARX and LIFE side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARX and LIFE compare
Accelerant is the larger company, worth 2.1 times as much as Ethos Technologies ($4.3B against $2.1B).
Accelerant grew revenue faster over the last twelve months (54.6% versus 52.0% for Ethos Technologies).
Ethos Technologies scores higher on the StockData Score (9 against 1 for Accelerant), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARX | LIFE |
|---|---|---|
| Size and price | ||
| Market cap | $4.3B | $2.1B |
| Share price | $19.86 | $32.80 |
| Change, 1 year | 46.5% | 1626% |
| Change, 5 years | 28.5% | – |
| Beta (5Y) | 0.34 | – |
| Employees | – | 614 |
| StockData Score | ||
| Total score | 1 | 9 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 26.9× |
| P/S | 3.8× (better) | 5.4× |
| P/B | 6.0× | 4.4× (better) |
| EV/EBITDA | – | 24.6× |
| P/FCF | – | 60.2× |
| FCF yield | – | 1.7% |
| Fair value | – | $33.82 |
| Margin of safety | – | 3.0% |
| Growth | ||
| Revenue growth (TTM) | 54.6% (better) | 52.0% |
| Net income growth (TTM) | – | 45.7% |
| EPS growth (TTM) | −3267% | 43.5% (better) |
| Profitability | ||
| Gross margin | – | 98.3% |
| Operating margin | – | 18.8% |
| Net margin | – | 18.4% |
| FCF margin | – | 9.0% |
| Return on equity | – | 38.6% |
| Return on invested capital | – | 141% |
| Financial health | ||
| Current ratio | – | 1.52 |
| Altman Z-score | 0.21 | 6.28 (better) |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Payout ratio | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 29.7% | 27.7% |
| Held by insiders | 73.7% | 74.7% |
| Insider net buying, 12 months | −$21.6M (better) | −$89.6M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.2% | 22.8% |
Go deeper
- ARX stock overview
- ARX income statement
- ARX valuation and score
- LIFE stock overview
- LIFE income statement
- LIFE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.